Improvement of Postoperative Sequelae After Supraspinatus Tendon Repair Surgery Through Ultrasound-Guided Complex Korean Medicine Treatment
Objectives: This study aims to evaluate the clinical effects of ultrasound-guided Acupotomy and Pharmacopuncture in patients experiencing complications after rotator cuff repair surgery, specifically addressing pain, fibrosis, and limited shoulder mobility.Methods: A 71-year-old female patient who underwent supraspinatus tendon repair in 2017 presented with persistent shoulder pain and restricted motion despite prior physiotherapy.Ultrasound-guided interventions were employed, including Acupotomy for adhesions and scar tissue and Pharmacopuncture injections (5% dextrose) targeting the lateral pectoral nerve, suprascapular nerve, and posterior shoulder capsule.Pain intensity was assessed using the Numerical Rating Scale (NRS) before and after treatment over 6 weeks across nine sessions.Results: After treatment, the patient experienced complete resolution of end-range shoulder pain.Follow-up one year post-treatment showed minimal recurrence of mild pain (NRS 1-2) with extensive shoulder use, but no significant functional impairment or severe pain relapse.Conclusion: Ultrasound-guided Acoupotomy and Pharmacopuncture effectively addressed postoperative complications such as fibrosis and neuropathic pain following rotator cuff surgery.Ultrasound guidance improved procedural accuracy, reducing risks of vascular or nerve injury and enhancing therapeutic outcomes.This case highlights the potential for these combined interventions to safely and effectively manage post-surgical complications.
Authors
- Kyungho Kang (ORCID: https://orcid.org/0000-0001-9448-0209)
- N Jung
Institutions
- Dunsan Korean Medicine Hospital (KR)
Publication Details
- Journal
- Journal of Korean Medical Society of Acupotomology
- Published
- 2024-12-30
- DOI
- https://doi.org/10.54461/jacupotomy.2024.8.2.143
- Citations
- 1
- Primary Topic
- Healthcare and Venom Research
- Type
- article
- Field-Weighted Citation Impact
- 0.45